Nemoto Kyorindo's GE-Nemoto Dual Shot Alpha, which features Body Weight Protocol (BWP), Linear Decay Protocol (LDP) and Dilution Phase Protocol. The BWP method tailors the protocol based on the patients weight and the contrast concentration. The LDP uses less contrast to deliver the same amount of enhancement, injection time and image quality as normal injector methods, said the company. The Dilution Phase Protocol delivers contrast and saline simultaneously, which is commonly used in cardiac imaging today.


Additional Content

News | Magnetic Resonance Imaging (MRI)

March 4, 2026 — The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to Bayer for the expanded ...

Time March 04, 2026
arrow
News | FDA

Nov. 25, 2025 —Bracco Diagnostics Inc. has announced that the U.S. Food and Drug Administration (FDA) has expanded the ...

Time November 26, 2025
arrow
Sponsored Content | Videos | Radiology Business

Bayer Radiology’s Barbara Ruhland and Thom Kinst discuss how radiology departments can address the many different ...

Time October 09, 2025
arrow
News | Mammography

April 12, 2024 — Bayer and Hologic, Inc. announced a first-of-its-kind collaboration to deliver a coordinated solution ...

Time April 12, 2024
arrow
News | Mammography

April 12, 2024 — GE HealthCare, a leader in breast health technology and diagnostics, will feature its latest breast ...

Time April 12, 2024
arrow
Subscribe Now